Cumberland Pharmaceuticals (CPIX) Income from Non-Controlling Interests (2016 - 2026)
Cumberland Pharmaceuticals' Income from Non-Controlling Interests history spans 16 years, with the latest figure at -$16950.0 for Q4 2025.
- On a quarterly basis, Income from Non-Controlling Interests fell 878.59% to -$16950.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$28583.0, a 179.28% decrease, with the full-year FY2025 number at -$28583.0, down 179.28% from a year prior.
- Income from Non-Controlling Interests hit -$16950.0 in Q4 2025 for Cumberland Pharmaceuticals, down from -$8282.0 in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for CPIX hit a ceiling of $43791.0 in Q1 2024 and a floor of -$36561.0 in Q4 2021.
- Historically, Income from Non-Controlling Interests has averaged -$10949.2 across 5 years, with a median of -$14254.0 in 2022.
- Biggest five-year swings in Income from Non-Controlling Interests: soared 320.08% in 2024 and later plummeted 878.59% in 2025.
- Tracing CPIX's Income from Non-Controlling Interests over 5 years: stood at -$36561.0 in 2021, then surged by 48.07% to -$18985.0 in 2022, then surged by 60.07% to -$7581.0 in 2023, then surged by 128.72% to $2177.0 in 2024, then plummeted by 878.59% to -$16950.0 in 2025.
- Business Quant data shows Income from Non-Controlling Interests for CPIX at -$16950.0 in Q4 2025, -$8282.0 in Q3 2025, and $5533.0 in Q2 2025.